On Nov. 26, 2014, Medtronic announced that it had received clearance from the US Federal Trade Commission to acquire Covidien. The agreement includes a commitment to divest certain assets related to Covidien s drug-coated balloon catheter product. Earlier in the month, Spectranetics announOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.